Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP (Q54125043)
scientific article published on September 1, 1998
Language:
(P31) (Q13442814)
(P304) 2964-2976
(P407) (Q1860)
(P433) 9
(P478) 16
(P577) Tuesday, September 1, 1998
Tuesday, September 1, 1998
(P921) (Q61643320)
(Q643839)
(Q423762)
(Q323936)
(P953) http://intl.jco.org/cgi/content/abstract/16/9/2964
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.9.2964
(P1433) (Q400292)
(P1476) "Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP" (language: en)
(P2093) E. K. Rowinsky
L. Smith
Y. M. Wang
P. Chaturvedi
M. Villalona
E. Campbell
C. Aylesworth
S. G. Eckhardt
L. Hammond
M. Kraynak
R. Drengler
J. Stephenson
M. W. Harding
D. D. Von Hoff
other details
description scientific article published on September 1, 1998

External Links